Otago Healthcare have started discussions to participate in the Orphan Drugs & Rare Diseases Global Congress 2016 to be held in London. “This congress is an […]
Otago welcome Richard Davey to the team. Richard Davey will be responsible for all aspects of the supply chain management when handling Orphan drug distribution within […]
Otago Healthcare finalises agreement with Specialist Biopharma company in India to commence market entry for the European territories of United Kingdom and France for their recombinant […]
Otago establishes offices in the United Arab Emirates. “Our commercial presence in the MENA region will allows us to work closer with our existing partners in […]
Otago Healthcare meet with The Oganisation for Rare Diseases (ORD) in India to share key experiences of the European rare diseases sector. “India has a very […]
Otago management in India meet with Specialist Biopharmaceutical companies looking to enter the European market with their Orphan Drugs in the Autoimmune and Oncology sector. “Our […]
Otago Healthcare agrees key partnership with specialist pharmaceutical distributor for introducing key Orphan Drug in Middle East. “This partnership with Amount is a real milestone for […]
Otago Healthcare finalises international partnering agreement with Azanta A/S for launch of their Orphan Drug in Middle East. This is a very exciting opportunity for Otago […]
Otago Healthcare enters into discussion with Azanta A/S to commercialise their Orphan Drug used across Middle East. “We have a great deal of experience and expertise […]
Otago Healthcare signs MOU with Azanta A/S to work on the commercial launch of their Orphan within Europe. “Europe is a strategic focus for Azanta A/S […]